The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

By Brooks Tracy   O’Loughlin Kieran   Minderman Hans   Bundy Brian   Ford Laurie   Vredenburg Michael   Bernacki Ralph   Priebe Waldemar   Baer Maria  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements

By Koren Erez   Apte Anjali   Sawant Rupa R.   Grunwald Jacob   Torchilin Vladimir P.  

Drug Delivery, Vol. 18, Iss. 5, 2011-07 ,pp. : 377-384

Informa Healthcare

Access to resources Recommend Favorite

Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 210-219

Bentham Science Publishers

Access to resources Recommend Favorite

The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins

By Luna-Tortós Carlos   Rambeck Bernhard   Jürgens Uwe   Löscher Wolfgang  

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2464-2470

Springer Publishing Company

Access to resources Recommend Favorite

Complexation of Cell-Penetrating Peptide–Polymer Conjugates with Polyanions Controls Cells Uptake of HPMA Copolymers and Anti-tumor Activity

By Shamay Yosi   Shpirt Lina   Ashkenasy Gonen   David Ayelet  

Pharmaceutical Research, Vol. 31, Iss. 3, 2014-03 ,pp. : 768-779

Springer Publishing Company

Access to resources Recommend Favorite